These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 29043167)
61. Mtb/HIV co-infection immune microenvironment subpopulations heterogeneity. Gao J; Huang X; Zhu Q; He H; Zhang J; Chen J; Wei C; Luo S; Yang S; Xie Z Int Immunopharmacol; 2024 Dec; 143(Pt 1):113341. PubMed ID: 39405943 [TBL] [Abstract][Full Text] [Related]
62. A decrease in PPD specific CD4 T cell CD38 and HLA-DR expression in pulmonary tuberculosis patients after 8 weeks of therapy correlates with successful anti-tuberculosis treatment. Priyanto H; Chua E; Hutchinson P; Nugraha J; Amin M J Clin Tuberc Other Mycobact Dis; 2021 Feb; 22():100214. PubMed ID: 33490641 [TBL] [Abstract][Full Text] [Related]
63. A Novel Humanized Mouse Model for HIV and Tuberculosis Co-infection Studies. Bohórquez JA; Adduri S; Ansari D; John S; Florence J; Adejare O; Singh G; Konduru N; Jagannath C; Yi G bioRxiv; 2024 Mar; ():. PubMed ID: 38496484 [TBL] [Abstract][Full Text] [Related]
65. Regulatory T cells in HIV immunotherapy. Macatangay BJ; Rinaldo CR HIV Ther; 2010 Nov; 4(6):639-647. PubMed ID: 21461400 [TBL] [Abstract][Full Text] [Related]
66. T Cell Responses during Human Immunodeficiency Virus/ Bohórquez JA; Jagannath C; Xu H; Wang X; Yi G Vaccines (Basel); 2024 Aug; 12(8):. PubMed ID: 39204027 [TBL] [Abstract][Full Text] [Related]
68. Urban Air Pollution Particulates Suppress Human T-Cell Responses to Ibironke O; Carranza C; Sarkar S; Torres M; Choi HT; Nwoko J; Black K; Quintana-Belmares R; Osornio-Vargas Á; Ohman-Strickland P; Schwander S Int J Environ Res Public Health; 2019 Oct; 16(21):. PubMed ID: 31731429 [TBL] [Abstract][Full Text] [Related]
69. Mechanistic insights on immunosenescence and chronic immune activation in HIV-tuberculosis co-infection. Shankar EM; Velu V; Kamarulzaman A; Larsson M World J Virol; 2015 Feb; 4(1):17-24. PubMed ID: 25674514 [TBL] [Abstract][Full Text] [Related]
70. HIV and Tuberculosis co-infection impacts T-cell activation markers but not the numbers subset of regulatory T-cells in HIV-1 infected patients. Mbow M; Santos NSS; Camara M; Ba A; Niang A; Daneau G; Wade D; Diallo AA; Toupane M; Diakhaté M; Lèye N; Diaw PA; Mboup S; Kestens L; Dieye TN Afr J Lab Med; 2013; 2(1):76. PubMed ID: 29043167 [TBL] [Abstract][Full Text] [Related]
71. HLA-DR expression on regulatory T cells is closely associated with the global immune activation in HIV-1 infected subjects naïve to antiretroviral therapy. Xiao J; Qian KL; Cao QH; Qiu CL; Qiu C; Xue YL; Zhang XY; Zhong P; Xu JQ; Li MY; Wang Y Chin Med J (Engl); 2011 Aug; 124(15):2340-6. PubMed ID: 21933566 [TBL] [Abstract][Full Text] [Related]
72. Impact of antiretroviral and tuberculosis therapies on CD4 Chiacchio T; Petruccioli E; Vanini V; Cuzzi G; La Manna MP; Orlando V; Pinnetti C; Sampaolesi A; Antinori A; Caccamo N; Goletti D Immunol Lett; 2018 Jun; 198():33-43. PubMed ID: 29635002 [TBL] [Abstract][Full Text] [Related]
73. Expansion and productive HIV-1 infection of Foxp3 positive CD4 T cells at pleural sites of HIV/TB co-infection. Hirsch CS; Baseke J; Kafuluma JL; Nserko M; Mayanja-Kizza H; Toossi Z J Clin Exp Immunol; 2016; 1(1):. PubMed ID: 28124031 [TBL] [Abstract][Full Text] [Related]
74. Immune activation and regulatory T cells in Mycobacterium tuberculosis infected lymph nodes. Sahmoudi K; Abbassi H; Bouklata N; El Alami MN; Sadak A; Burant C; Henry Boom W; El Aouad R; Canaday DH; Seghrouchni F BMC Immunol; 2018 Nov; 19(1):33. PubMed ID: 30409122 [TBL] [Abstract][Full Text] [Related]
75. CD4+CD25+CD127- assessment as a surrogate phenotype for FOXP3+ regulatory T cells in HIV-1 infected viremic and aviremic subjects. Saison J; Demaret J; Venet F; Chidiac C; Malcus C; Poitevin-Later F; Tardy JC; Ferry T; Monneret G Cytometry B Clin Cytom; 2013; 84(1):50-4. PubMed ID: 23019018 [TBL] [Abstract][Full Text] [Related]